ENTITY
SillaJen Inc

SillaJen Inc (215600 KS)

51
Analysis
Health CareSouth Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
04 Sep 2019 07:06

Korea Short Interest - SillaJen Tends to Zero

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 30 August.Current...

Logo
455 Views
Share
21 Aug 2019 05:40

Korea Short Interest - Numb3rs & Ch@rts

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 16 August. Current...

Logo
469 Views
Share
bullishIcure Pharm Inc
02 Jun 2018 11:48

Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race

Icure Pharm Inc (175250 KS) will offer a total of 1,200,000 shares (100% new rights offering) at ₩44,000 - ₩55,000 which gives a market cap of...

Logo
277 Views
Share
30 Mar 2018 07:34

EM Managers: Most Avoided Stocks - 2018 Update

In this report, we screen for stocks that are largely avoided by global emerging market active funds. We identify companies within the MSCI...

Logo
224 Views
Share
25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
508 Views
Share
x